Abstract
In the normal myocardium matrix metalloproteinases (MMP) are present in the latent form. To examine whether MMP are activated following infarction or idiopathic dilated cardiomyopathy (DCM), we extracted and measured MMP activity in tissue derived from 7 explanted, failing human hearts due to either previous myocardial infarction (MI) or DCM. MMP activity in infarcted left ventricle (LV), noninfarcted IV and right ventricle (RV) from MI patients, as well as tissue from either ventricle of DCM patients, were compared to the activity of donor heart tissue. SDS-PAGE and dye-binding assays were used to determine total protein concentration, while collagenase activity was measured by SDS-PAGE type substrate gels embedded with type I gelatin (zymography). Accuracy of the zymographic technique was shown for tissue samples as small as 0.05 mg and was comparable to results obtained by a spectrophotometric method.. After normalization for total protein concentration, we found 3 ± 1 % collagenase activity in normal atrial tissue which could be activated to 80–90% by trypsin or plasmin, indicating that collagenase is normally inactive or in a latent form in human heart. In endo- and epimyocardium of infarcted LV on the other hand, collagenase activity was 85–95% and 10–20%, respectively, while 5–10% and 3–5%, respectively, in noninfarcted LV In DCM, collagenolytic activity in the endo and epimyocardium was 75 ± 5 and 35 ± 5% in the LV and 35 ± 7 and 20 ± 5% in the RV, respectively. Thus, in dilated failing human hearts secondary to previous MI or DCM, MMP activity is increased. This is particularly the case within the endomyocardium of the infarcted and noninfarcted portions of either ventricle with MI and in both ventricles in DCM. This suggests that an activation of collagenase throughout the myocardium may contribute to its remodeling that includes ventricular dilatation and wall thinning.
Similar content being viewed by others
References
Borg TK, Burgess ML: Holding it all together: organization and function (s) of the extracellular matrix of the heart. Heart Failure 8: 230–238, 1993
Weber KT, Sun Y, Tyagi SC, Cleutjens J: Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279–292, 1994
Weber KT: Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13: 1637–52, 1989
Olivetti G, Capasso JM, Sonnenblick EH, Anversa P: Side-to side slippage of myocytes participates in ventricular wall remodeling acurely after myocardial infarction in rats. Cir Res 67: 23–34, 1990
Motz W, Strauer BE: Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 34: 43–50, 1989
Iimoto DS, Covell JW, Harper E: Increase in cross-linking of type I and III collagens associated with volume-overload hypertrophy. Cir Res 63: 399–408, 1988
Weber KT, Pick R, Silver MA, Moe GW, Janicki JS, Zucker IH, Armstrong PW: Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation 82: 1387–1401, 1990
Cannon RO, Butany JW, McManus BM, Speir E, Kravits AB, Billi R, Ferrans VJ: Early degradation of collagen after acute myocardial infarction in the rat, Am J Cardiol 52: 390–395, 1983
Sato S, Ashraf M, Millard RW, Fujiwara H, Schwartz A. Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J Mol Cell Cardiol 15: 261–75, 1983
Weber KT, Pick R, Janicki JS, Gadodia G, Lakier JB: Inadequate collagen tethers in dilated cardiopathy. Am Heart J 116: 1641–1646, 1988
Weber KT, Pick R, Silver MA, Moe GW, Janicki JS, Zucker IH, et al.: Fibrillar collagen and the remodeling of the dilated canine left ventricle. Circulation 82: 1387–1401, 1990
Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR: Collagen remodeling and changes in LV function during development and recovery from supraventricular tachyvardia. Am J Physiol 261: H308-H318, 1991
Tyagi, SC, Matsubara, L, Ratajska A., Weber KT: Identification and localization of myocardial collagenase(s). Clin Res 40: 757A, 1992
Tyagi SC, Matsubara L, Weber KT: Direct extraction and estimation of collagenase(s) activity by zymography in microquantitites of rat myocardium and uterus. Clin Biochem 26: 191–198, 1993
Tyagi SC, Ratajska A, Weber KT: Myocardial matrix metalloproteinases: localization and activation. Mol Cell Biochem 126: 49–59, 1993
Cleutjens JP, Kandala JC, Guardo E, Guntaka RV, Weber KT: Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27: 1281–1292, 1995
Tyagi SC, Simon SR: Role of disulfide exchange in alpha-1 protease inhibitor. Biochemistry 31: 10584–10590, 1992
Masui Y, Takemoto T, Sakakibara S, Hori H, Nagai Y: Synthetic substrates for vertebrate collagenase. Biochem Med 17: 215–221, 1977
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72: 248–254, 1976
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Tyagi SC, Kumar SG, Glover G: Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J Cell Biochem 58: 360–371, 1995
Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC, Cruickshank JM, Devereux RB, Giles TD, Corsgaard N, Leier CV, Mendelsohn FAO, Motz WH, Mulvany MJ, Strauer BE: Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 20: 3–16, 1992
Tyagi SC, Kumar SG, Banks J, Fortson W: Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium, J Mol Cell Cardiol 27: 2177–2189, 1995
Factor SM: Role of extracellular matrix in dilated cardiomyopathy. Heart Failure 260–268, 1994
Newman KM, Malon AM, Shin R, et al.: Matrix metalloproteinases in abdominal aortic aneurysm disease. FASEB J 6: A1915 (Abstract), 1992
Campbell SE, Diaz-Arias AA, Weber KT: Ventricle rupture and fibrillar collagen degradation, Circulation 84 (suppl II): 22–32, 1991
Reddy HK, Tyagi SC, Tjahja IE, Voelker DJ, Campbell SE, Weber KT: Enhanced endomyocardial collagenase activity in dilated cardiomyopathy: A marker of dilatation and architectural remodeling. Circulation 88 part 2: 1–407, 1993
Bonnin CM, Sparrow MP, Taylor RR: Collagen synthesis and content in right ventricular hypertrophy in the dog. Am J Physiol 10: H703–713, 1981
Laurent GJ: Dynamic state of collagen: pathways of collagen degradationin vivo and their possible role in regulation of collagen mass. Am J Physiol 252: C1-C9, 1987
Okada Y, Watanabe S, Nakanishi I, et al.: Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 229: 157–160, 1988
Author information
Authors and Affiliations
Additional information
This work was supported in part by NIH grant GM-48595 and by a Grant-In-Aid from the American Heart Association, Missouri Affiliate (92-10517).
Rights and permissions
About this article
Cite this article
Tyagi, S.C., Campbell, S.E., Reddy, H.K. et al. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 155, 13–21 (1996). https://doi.org/10.1007/BF00714328
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00714328